Skip to main content

Advertisement

Log in

The specific case of radiopharmaceuticals and GMP—activities of the Radiopharmacy Committee

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Långström B, Hartvig P. GMP—three letters with many interpretations: protection of patients or killing the clinical and research applications of PET. Eur J Nucl Med Mol Imaging 2008;35:693–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to C. Decristoforo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Decristoforo, C., Elsinga, P., Faivre-Chauvet, A. et al. The specific case of radiopharmaceuticals and GMP—activities of the Radiopharmacy Committee. Eur J Nucl Med Mol Imaging 35, 1400–1401 (2008). https://doi.org/10.1007/s00259-008-0827-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-0827-9

Keywords

Navigation